These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 25894122
1. Trends in ABO-incompatible kidney transplantation. Aikawa A, Saito K, Takahashi K. Exp Clin Transplant; 2015 Apr; 13 Suppl 1():18-22. PubMed ID: 25894122 [Abstract] [Full Text] [Related]
2. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis. Han S, Hwang E, Park S, Park U, Kim H, Cho W. Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367 [Abstract] [Full Text] [Related]
3. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Becker LE, Siebert D, Süsal C, Opelz G, Leo A, Waldherr R, Macher-Goeppinger S, Schemmer P, Schaefer SM, Klein K, Beimler J, Zeier M, Schwenger V, Morath C. Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497 [Abstract] [Full Text] [Related]
4. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Takahashi K, Saito K, Takahara S, Fuchinoue S, Yagisawa T, Aikawa A, Watarai Y, Yoshimura N, Tanabe K, Morozumi K, Shimazu M, IDEC-C2B8 ABO-I KTx Study Group. Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951 [Abstract] [Full Text] [Related]
7. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant. Hamasaki Y, Aikawa A, Itabashi Y, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Kawamura T, Sakai K, Shishido S. Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532 [Abstract] [Full Text] [Related]
8. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry. Hattori M, Mieno M, Shishido S, Aikawa A, Ushigome H, Ohshima S, Takahashi K, Hasegawa A, Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation. Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948 [Abstract] [Full Text] [Related]
13. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report. Nishimura H, Yamada Y, Hisano S, Mitsuke A, Tatarano S, Gotanda T, Hayami H, Nakagawa M, Enokida H. BMC Nephrol; 2018 Oct 05; 19(1):254. PubMed ID: 30290778 [Abstract] [Full Text] [Related]
14. ABO-incompatible kidney transplantation: long-term outcomes. Tanabe K, Ishida H, Inui M, Okumi M, Shirakawa H, Shimizu T, Omoto K, Kondo T. Clin Transpl; 2013 Oct 05; ():307-12. PubMed ID: 25095522 [Abstract] [Full Text] [Related]
20. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports. Koshino K, Okamoto M, Sakai K, Suzuki T, Nobori S, Matsuyama M, Ushigome H, Okajima H, Yoshimura N. Transplant Proc; 2011 Oct 05; 43(6):2379-82. PubMed ID: 21839272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]